Back to search
de Novo Kidney Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which de Novo Kidney Transplantation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which de Novo Kidney Transplantation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The objectives of this study are to test the preliminary safety and efficacy of a two-day peri-operative course of treprostinil in reducing ischemia-reperfusion…
Medications used after transplant to prevent rejection are associated with many side effects. Tacrolimus side effects include kidney dysfunction; tremor, headac…
The study titled "Daratumumab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients with De Novo Donor-Specific Antibodies" (DARTABMR) is a case-…
The main objective of this protocol is to compare the impact on renal function of two different immunosuppressive regimens in patients with de novo renal transp…
Antibody mediated rejection (ABMR) is a major cause of graft loss after kidney transplantation (KT) and is mainly associated with preformed anti-HLA donor speci…